7ea951b6 B020 481f 8acc 12fb7a3a69fd 01
Topiramate Tablet, Film Coated
Product Images NDC 50090-5309
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-5309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
7ea951b6 B020 481f 8acc 12fb7a3a69fd 02
7ea951b6 B020 481f 8acc 12fb7a3a69fd 03
The text shows a table indicating the changes in the average monthly migraine period rate from baseline to the double-blind phase for Placebo and different doses of Topiramate. There are also some statistical values presented, such as P-values.*
Label Image (Lbl500905309)
This text is not readable. Please provide a valid text for evaluation.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
